M K Exim (India): Jun 2025 — Profit Grows, Debtor Days Swell
Spotted a factual error — a wrong number, date, or fact? Tell us and we will check the source.
General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
M K Exim reported its Jun 2025 quarter with net profit up 77.6% year-on-year to ₹6.18 crore, while revenue dipped marginally by 0.11% to ₹26.34 crore. The operational pulse stayed strong—OPM hit 28.4% this quarter—but a few warning lights flickered beneath. Debtor days stretched from 71 to 87 over the past year, a 16-day slip that hints at collection strain. Inventory days ballooned to 328 against a long-term median of 51, a red flag. Cash conversion cycle deteriorated sharply to 400 days from 213.
The company operates two broad worlds: cosmetics distribution (now ~70% of revenue, growing faster) and fabric manufacturing (shrinking). Recent promoter buying signals conviction—Murli Dialani scooped up 105k shares in mid-June. The multiple sits at 12.6x earnings, well below both peer median (30.4x) and the company’s own 5-year historical average.
Does cheap necessarily mean safe? Not when working capital management is spinning out of control.
2. Introduction
Incorporated in 1992, M K Exim wears two hats uneasily. The fabric weaving, processing, and finishing arm (polyester-viscose blends, worsted suitings, premium wool suits) once anchored the business. Today it’s a footnote: ₹145.8 lakh in FY26 (1.5% of sales), down from ₹191.6 lakh (2.1%) just a year prior.
Cosmetics took centre stage. The company holds exclusive Indian distributorships for Moroccan Oil, John Paul Mitchell Systems, BCL Spa, and K18 Biometic Hair Science—premium, imported brands trading on sophistication and price power. This segment drove ₹78.86 crore in FY25 (84.8% of sales) and expanded further in FY26.
The company also maintains relief-program supply contracts (blankets, mats) and a historical export business, though both have become afterthoughts. It remains a Government Recognized Export House and registered with the Synthetic & Rayon Textiles Export Promotion Council.
On paper: a boring distributor. In practice: a working capital nightmare dressed in growth clothes.
3. Business Model: WTF Do They Even Do?
The cosmetics distribution play is straightforward. Import premium, marginally-localized haircare and beauty products; retail them through India’s salon, salon-supply, and e-commerce channels. Gross margins on FMCG are thin relative to branded goods, but the company extracts 28.4% OPM, hinting at efficient SG&A discipline and minimal competition on these specific distribution partnerships.
The math works until it doesn’t. Inventory days of 328 against a 5-year average of 75 suggests either (a) a supply chain hiccup, (b) weak demand causing stockpile build, or (c) a one-off import consignment timing mismatch. Without the concall, the guess is open.
Debtors (mostly retail and salon chains on credit terms) have ballooned. The company collected in 57 days back in FY24; by Jun 2025, that stretched to 87 days. Multiply that by ₹26.34 crore quarterly revenue and the working capital drag becomes palpable—cash tied up in the distribution system longer, suppliers paid on tighter terms.
The fabric segment still exists as a Tier-2 product category, but it’s a zombie: low volume, margin-dependent, and ignored by management in disclosures. Relief supplies are sporadic—₹0 in FY26 (down from ₹205 lakh in FY25)—suggesting contract wins/losses drive lumpy revenue.
Brands matter only insofar as they’re exclusive. Without the JPMS or Moroccan Oil licenses, the company is just another distributor in a field of thousands. The moat is thin and contractual, not defensible.
4. Financials Overview
Figures are consolidated, in ₹ crore.
Metric
Jun 2025 (Q1)
YoY Change
QoQ Change (vs Mar 2025)
Revenue
26.34
-0.11%
+0.16%
EBITDA
9.22
+64.5%
+115.3%
PAT
6.18
+77.6%
+77.6%
EPS (annualised from Q)
1.53 ×4 = 6.12
—
—
The quarter revealed earnings momentum masked by revenue flatness. Operating profit jumped 41% YoY to ₹7.48 crore (OPM 28.4%), and PAT surged 77.6%—a margin expansion story, not a volume story. Other income ticked up to ₹1.30 crore (vs ₹0.23 crore a year ago), a nice cushion but not a trend to bank on.
Interest expense fell sharply to ₹0.05 crore, reflecting the company’s near-zero debt posture (₹1.75 crore total borrowings against ₹252 crore market cap). Tax rate remained stable at 27.3%.
The profit surge is real. But it’s also fragile: built on a single quarter of volume execution and margin realization. Debtor days creeping up signal that this revenue growth is being purchased on credit—a red flag for cash generation.
5. Market Expectations & Historical Multiples
This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.
Metric
Current
5-Yr Average
Peer Median
Interpretation
P/E
12.6×
18.2×
30.4×
The market pays 12.6x earnings here, half its own historical norm and a third of the peer median.
EV/EBITDA
8.08×
12.1×
—
Enterprise value sits at 8.08x EBITDA, a 33% discount to the company’s own 5-year average.
Price-to-Book
2.09×
2.8×
—
The book value multiple has compressed by 25% from historical levels.
ROE
18.4%
19.6%
—
Return on equity remains solid; the compression in price reflects external skepticism, not operational decay.
ROCE
24.7%
28.0%
13.7% (median)
Capital returns remain well above both peer set and the company’s own cost of capital.
The market is currently pricing in a structural headwind: the belief that cosmetics distribution in India faces margin compression, inventory risk, or demand slowdown. Historical P/E of 18.2x and the peer median of 30.4x suggest the stock once commanded a premium, or peers still do. The 12.6x multiple reflects either a discount for quality (a contrarian read) or a discount for risk (the orthodox read).
What the multiples appear to price in: (a) working capital deterioration (visible in inventory and debtor days), (b) revenue volatility (Jun 2025 was flat), and (c) the possibility that the cosmetics import business faces cyclical headwinds or